Glucagonoma laboratory tests: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
Line 1: Line 1:
__NOTOC__
{{Glucagonoma}}
{{Glucagonoma}}
{{CMG}}
{{CMG}}


==Overview==
==Overview==
A [[blood serum]] glucagon concentration of 1000 pg/mL or greater is indicative of glucagonoma (the normal range is 50-200 pg/mL).


Blood tests may also reveal abnormally low concentrations of amino acids, [[zinc]], and [[essential fatty acid]]s, which are thought to play a role in the development of NME. Skin [[biopsy|biopsies]] may also be taken to confirm the presence of NME.
==Laboratory Findings==


A [[complete blood count|CBC]] can uncover anemia, which is an abnormally low level of [[hemoglobin]].
* A [[blood serum]] glucagon concentration of 1000 pg/mL or greater is indicative of glucagonoma (the normal range is 50-200 pg/mL).


The tumor itself may be localized by any number of radiographic modalities, including [[angiography]], [[computed tomography|CT]], [[magnetic resonance imaging|MRI]], [[positron emission tomography|PET]], and [[endoscopic ultrasound]]. [[Laparotomy]] is useful for obtaining [[histology|histologic]] samples for analysis and confirmation of the glucagonoma.
* Blood tests may also reveal abnormally low concentrations of amino acids, [[zinc]], and [[essential fatty acid]]s, which are thought to play a role in the development of NME.
 
* A [[complete blood count|CBC]] can uncover anemia, which is an abnormally low level of [[hemoglobin]].


==References==
==References==
{{reflist|2}}
{{reflist|2}}


[[Category:Disease]]
[[Category:Neurology]]
[[Category:Types of cancer]]
[[Category:Types of cancer]]
[[Category:Neurosurgery]]
[[Category:Oncology]]
[[Category:Oncology]]


{{WikiDoc Help Menu}}
{{WikiDoc Help Menu}}
{{WikiDoc Sources}}
{{WikiDoc Sources}}

Revision as of 17:56, 14 September 2012

Glucagonoma Microchapters

Home

Patient Information

Overview

Historical Perspective

Pathophysiology

Causes

Differentiating Glucagonoma from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Staging

History and Symptoms

Physical Examination

Laboratory Findings

Chest X Ray

CT

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Glucagonoma laboratory tests On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Glucagonoma laboratory tests

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Glucagonoma laboratory tests

CDC on Glucagonoma laboratory tests

Glucagonoma laboratory tests in the news

Blogs on Glucagonoma laboratory tests

Directions to Hospitals Treating Glucagonoma

Risk calculators and risk factors for Glucagonoma laboratory tests

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Laboratory Findings

  • A blood serum glucagon concentration of 1000 pg/mL or greater is indicative of glucagonoma (the normal range is 50-200 pg/mL).
  • Blood tests may also reveal abnormally low concentrations of amino acids, zinc, and essential fatty acids, which are thought to play a role in the development of NME.
  • A CBC can uncover anemia, which is an abnormally low level of hemoglobin.

References


Template:WikiDoc Sources